Intraoperative indocyanine green fluorescence in canine meningioma: macroscopic visualization, immediate MRI correlation, and clinical outcomes : a case series.
5 affiliations
- 1Department of Veterinary Surgery, Bon Animal Medical Center, Suwon, 16305, Republic of Korea.
- 2Department of Veterinary Surgery, College of Veterinary Medicine, Konkuk University, Seoul, 05029, Republic of Korea.
- 3Department of Veterinary Radiology, Bon Animal Medical Center, Suwon, 16305, Republic of Korea.
- 4Department of Veterinary Surgery, Bon Animal Medical Center, Suwon, 16305, Republic of Korea. [email protected].
- 5Department of Veterinary Surgery, College of Veterinary Medicine, Konkuk University, Seoul, 05029, Republic of Korea. [email protected].
Abstract
Background
Meningioma is the most common primary intracranial neoplasm in dogs, frequently presenting with seizures and focal neurological deficits. While indocyanine green (ICG) near-infrared (NIR) fluorescence is increasingly used in human neurosurgery, systematic data regarding the macroscopic fluorescence emitted by accumulated ICG in canine meningiomas remain scarce. This case series aimed to evaluate the fluorescent signals emitted from the tumors, correlate intraoperative findings using immediate post-operative contrast-enhanced magnetic resonance imaging (MRI), and report the clinical outcomes and post-operative management following fluorescence-guided surgery (FGS).Case presentation
Six client-owned dogs (median age: 13 years) with histologically confirmed meningiomas were evaluated. ICG was administered intravenously (2.5-5.0 mg/kg, median dose: 4.5 mg/kg) 6 to 24 h prior to surgery. FGS was performed using an ultrasonic aspirator and a dedicated fluorescence imaging system. Distinct margin fluorescence was observed in all 6 cases (100%), allowing for real-time differentiation between tumor tissue and grossly normal brain parenchyma during resection. Immediate post-operative T1-weighted contrast-enhanced MRI demonstrated 100% concordance with intraoperative wound bed fluorescence assessments when thin reactive rims (≤ 1-2 mm) were appropriately excluded. No adverse reactions were associated with ICG. The median follow-up was 14 months (range: 6.6 to 31.0 months), with favorable neurological control.Conclusions
Utilizing a second-window approach with dynamic working distance control, ICG effectively demarcated macroscopic canine meningiomas in this small cohort. Immediate post-operative MRI correlated well with surgeon's intraoperative assessments. Ultimately, FGS may serve as a viable surgical option to help minimize damage to grossly normal brain tissue and potentially improve surgical outcomes in canine meningioma.
Related
- The Role of Intraoperative Indocyanine Green Fluorescence Angiography in Reducing Anastomotic Leak After Colorectal Resection: A Systematic Review of Randomised Controlled Trials
- Intraoperative Indocyanine Green Fluorescence for Assessment of Suspected Venous Invasion in a Dog With Thyroid Carcinoma.
- Second-Window Indocyanine Green fluorescence imaging differentiates inflammation from necrotic tissue in early burn wounds
- Indocyanine green fluorescence-guided surgery in acute settings: state-of-the art
- Optimizing Indocyanine Green Fluorescence Cholangiography in Laparoscopic Cholecystectomy: A Systematic Review of Randomized Controlled Trials on Dose, Timing, Route, Efficacy, and Safety
BibTeX
@article{kim2026intraoperative,
title = {{Intraoperative indocyanine green fluorescence in canine meningioma: macroscopic visualization, immediate MRI correlation, and clinical outcomes : a case series.}},
author = {Youngbeum Kim and Mihyun Choi and Yongsun Kim and Hwi-Yool Kim},
journal = {BMC veterinary research},
year = {2026},
month = aug,
doi = {10.1186/s12917-026-05782-4},
url = {https://europepmc.org/article/MED/42968180},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Intraoperative indocyanine green fluorescence in canine meningioma: macroscopic visualization, immediate MRI correlation, and clinical outcomes : a case series.
AU - Youngbeum Kim
AU - Mihyun Choi
AU - Yongsun Kim
AU - Hwi-Yool Kim
PY - 2026
DA - 2026/08/03
JO - BMC veterinary research
DO - 10.1186/s12917-026-05782-4
UR - https://europepmc.org/article/MED/42968180
AB - Background Meningioma is the most common primary intracranial neoplasm in dogs, frequently presenting with seizures and focal neurological deficits. While indocyanine green (ICG) near-infrared (NIR) fluorescence is increasingly used in human neurosurgery, systematic data regarding the macroscopic fluorescence emitted by accumulated ICG in canine meningiomas remain scarce. This case series aimed to evaluate the fluorescent signals emitted from the tumors, correlate intraoperative findings using immediate post-operative contrast-enhanced magnetic resonance imaging (MRI), and report the clinical outcomes and post-operative management following fluorescence-guided surgery (FGS).Case presentation Six client-owned dogs (median age: 13 years) with histologically confirmed meningiomas were evaluated. ICG was administered intravenously (2.5-5.0 mg/kg, median dose: 4.5 mg/kg) 6 to 24 h prior to surgery. FGS was performed using an ultrasonic aspirator and a dedicated fluorescence imaging system. Distinct margin fluorescence was observed in all 6 cases (100%), allowing for real-time differentiation between tumor tissue and grossly normal brain parenchyma during resection. Immediate post-operative T1-weighted contrast-enhanced MRI demonstrated 100% concordance with intraoperative wound bed fluorescence assessments when thin reactive rims (≤ 1-2 mm) were appropriately excluded. No adverse reactions were associated with ICG. The median follow-up was 14 months (range: 6.6 to 31.0 months), with favorable neurological control.Conclusions Utilizing a second-window approach with dynamic working distance control, ICG effectively demarcated macroscopic canine meningiomas in this small cohort. Immediate post-operative MRI correlated well with surgeon's intraoperative assessments. Ultimately, FGS may serve as a viable surgical option to help minimize damage to grossly normal brain tissue and potentially improve surgical outcomes in canine meningioma.
SN - 1746-6148
ER -